Requires health insurers to provide coverage for treatment of tick-borne diseases.
Impact
The introduction of SB 400 is expected to have a substantial impact on state health laws, specifically in enhancing the coverage offered by health insurers. By classifying treatment for tick-borne diseases as a necessary coverage, the bill aligns with medical recommendations and may lead to improved health outcomes. Patients suffering from these diseases will have improved access to necessary treatments without the fear of insurance denial, particularly for options considered experimental or investigational. This could potentially lead to a significant increase in early intervention and treatment, which is crucial for diseases that can progress quickly.
Summary
Senate Bill 400, proposed in New Jersey, aims to mandate health insurers to provide coverage for the treatment of tick-borne diseases. Specifically, this bill requires that health insurance plans cover expenses related to medically necessary treatments prescribed by physicians, including long-term antibiotic therapy, which refers to the administration of antibiotics for over four weeks. This initiative is particularly significant given the increasing prevalence of tick-borne diseases, which can lead to severe health issues if not properly addressed.
Contention
Despite the perceived benefits, SB 400 may face opposition, primarily from insurance companies concerned about the financial implications of mandating such coverage. Critics may argue that the classification of certain treatments as medically necessary could result in increased premium costs for all insured individuals. Additionally, there may be concerns regarding the broad definition of tick-borne diseases and the pressure it might place on insurers to cover a wide array of treatments. Addressing these concerns will be essential for gaining broader support for the bill and ensuring that it can be effectively implemented.
Providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.
Requires health insurers to provide coverage for long term medical care for Lyme disease and other tick borne related pathogens; provides for taxpayer gifts for tick borne illness research, detection and education; establishes the tick borne illness research, detection and education fund.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)